Karleen Marie Oberton Sells 546 Shares of Hologic, Inc. (HOLX) Stock

Hologic, Inc. (NASDAQ:HOLX) CFO Karleen Marie Oberton sold 546 shares of the stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $39.96, for a total transaction of $21,818.16. Following the sale, the chief financial officer now owns 10,206 shares of the company’s stock, valued at $407,831.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Karleen Marie Oberton also recently made the following trade(s):

  • On Thursday, November 8th, Karleen Marie Oberton sold 1,312 shares of Hologic stock. The stock was sold at an average price of $41.90, for a total transaction of $54,972.80.

Shares of HOLX opened at $41.78 on Friday. The company has a quick ratio of 0.99, a current ratio of 1.29 and a debt-to-equity ratio of 1.12. Hologic, Inc. has a one year low of $35.10 and a one year high of $45.09. The stock has a market capitalization of $11.23 billion, a price-to-earnings ratio of 18.74, a P/E/G ratio of 1.88 and a beta of 0.65.

Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Wednesday, November 7th. The medical equipment provider reported $0.58 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.59 by ($0.01). Hologic had a positive return on equity of 22.93% and a negative net margin of 3.46%. The company had revenue of $813.50 million during the quarter, compared to analysts’ expectations of $808.63 million. During the same quarter last year, the business earned $0.50 earnings per share. The business’s quarterly revenue was up 1.3% on a year-over-year basis. Sell-side analysts predict that Hologic, Inc. will post 2.4 EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Jane Street Group LLC lifted its holdings in shares of Hologic by 30.3% during the first quarter. Jane Street Group LLC now owns 6,904 shares of the medical equipment provider’s stock valued at $258,000 after purchasing an additional 1,607 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Hologic by 0.5% during the first quarter. Principal Financial Group Inc. now owns 406,319 shares of the medical equipment provider’s stock valued at $15,180,000 after purchasing an additional 2,131 shares during the last quarter. DnB Asset Management AS purchased a new position in shares of Hologic during the second quarter valued at approximately $1,248,000. IFM Investors Pty Ltd lifted its holdings in shares of Hologic by 40.6% during the second quarter. IFM Investors Pty Ltd now owns 14,129 shares of the medical equipment provider’s stock valued at $562,000 after purchasing an additional 4,080 shares during the last quarter. Finally, Thompson Investment Management Inc. lifted its holdings in shares of Hologic by 2.2% during the second quarter. Thompson Investment Management Inc. now owns 82,333 shares of the medical equipment provider’s stock valued at $3,273,000 after purchasing an additional 1,753 shares during the last quarter. Institutional investors and hedge funds own 98.74% of the company’s stock.

HOLX has been the subject of a number of analyst reports. Bank of America lowered shares of Hologic from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $47.00 to $42.00 in a report on Thursday, September 13th. BidaskClub lowered shares of Hologic from a “hold” rating to a “sell” rating in a report on Thursday, August 16th. Zacks Investment Research lowered shares of Hologic from a “hold” rating to a “sell” rating in a report on Tuesday, October 9th. Canaccord Genuity increased their target price on shares of Hologic from $40.00 to $41.00 and gave the stock a “hold” rating in a report on Thursday, September 27th. Finally, Piper Jaffray Companies dropped their target price on shares of Hologic to $45.00 and set an “overweight” rating for the company in a report on Thursday. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eight have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $44.41.

ILLEGAL ACTIVITY NOTICE: “Karleen Marie Oberton Sells 546 Shares of Hologic, Inc. (HOLX) Stock” was originally reported by WKRB News and is the property of of WKRB News. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.wkrb13.com/2018/11/10/karleen-marie-oberton-sells-546-shares-of-hologic-inc-holx-stock.html.

Hologic Company Profile

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Further Reading: What does cost of debt say about a company’s financial health?

Insider Buying and Selling by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply